Release Date: 23/12/15 18:19 Summary: Replacement Bidder's Statement Price Sensitive: No Download Document 2.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%